Iveric Bio Inc reports results for the quarter ended in March - Earnings Summary

IVERIC bio

04/05/2022 14:32

* Iveric Bio Inc  ISEE.OQ  reported a quarterly adjusted
loss
of 29 cents​​ per share for the quarter ended in March. The mean
expectation of six analysts for the quarter was for a loss of 29
cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Iveric Bio Inc's reported EPS for the quarter was a loss
of 29
cents​.
    * The mean earnings estimate of analysts had fallen by
about 24.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Iveric Bio Inc shares had fallen by 13.4% this quarter and
lost 12.9% so far this year.
    * The company reported a quarterly loss of $34.54 million.
    * Wall Street's median 12-month price target for Iveric Bio
Inc is
$25.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 4 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated